Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.


Mayo Clinic doctors and scientists are actively studying ways to improve bone marrow transplant outcomes. Areas of research include:

  • Expanding the use of haploidentical bone marrow transplant
  • Finding new ways to use bone marrow transplant, including pediatric hemoglobinopathies and inherited metabolic diseases
  • Improving quality of life for bone marrow transplant survivors
  • Preventing and managing graft-versus-host disease (GVHD)
  • Understanding chronic GVHD

Learn more about research in the Bone Marrow Transplant Program.

Cancer research is conducted in coordination with the Mayo Clinic Cancer Center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.


See a list of publications about bone marrow transplant by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Research Profiles

Bone marrow transplant care at Mayo Clinic

Oct. 24, 2019
  1. AskMayoExpert. Hematopoietic stem cell transplant. Mayo Clinic; 2019.
  2. Hoffman R, et al. Overview of hematopoietic stem cell transplantation. In: Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2013. Accessed July 8, 2016.
  3. Blood-forming stem cell transplants. National Cancer Institute. Accessed July 8, 2016.
  4. Majhail NS, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation. 2012;18:348.
  5. Diseases treatable by transplants. National Marrow Donor Program. Accessed Aug. 1, 2019.
  6. AskMayoExpert. Graft-versus-host disease. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  7. Blood and marrow stem cell transplantation. Leukemia & Lymphoma Society. Accessed Aug. 1, 2019.
  8. Barbara Woodward Lips Patient Education Center. Autologous stem cell transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
  9. Blood and bone marrow transplant. National Heart, Lung, and Blood Institute. Accessed Aug. 13, 2019.
  10. D'Souza A, et al. Current use and trends in hematopoietic cell transplantation in the United States. Biology of Blood and Marrow Transplantation. 2017; doi:10.1016/j.bbmt.2017.05.035.
  11. Jagasia MH, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation. 2015; doi:10.1016/j.bbmt.2014.12.001.
  12. Blood and marrow transplant (BMT): An introduction to allogeneic BMT. Leukemia & Lymphoma Society. Accessed Aug. 1, 2019.
  13. Majhail NS. Long term complications after hematopoietic cell transplantation. Hematology Oncology Stem Cell Therapy. 2017; doi:10.1016/j.hemonc.2017.05.009.
  14. Hashmi SK, et al. National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group report. Biology of Blood and Marrow Transplantation. 2017; doi:10.1016/j.bbmt.2016.09.025.
  15. DeFilipp Z, et al. Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: Screening and preventive practice recommendations from CIBMTR and EBMT. Biology of Blood and Marrow Transplantation. 2016; doi:10.1038/bmt.2016.203.
  16. Mills SD, et al. Bone-marrow transplant in an identical twin. JAMA. 1964; doi:10.1001/jama.1964.03060380005001.
  17. Rashidi A, et al. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Advances. 2019; doi:10.1182/bloodadvances.2019000050.
  18. Ahmed S, et al. Lower graft-versus-host disease and relapse risk in post-transplant cyclophosphamide-based haploidentical versus matched sibling donor reduced-intensity conditioning transplant for Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2019.05.025.
  19. Jain T, et al. Choosing a reduced-intensity conditioning regimen for allogeneic stem cell transplantation, fludarabine/busulfan versus fludarabine melphalan: A systematic review and meta-analysis. Biology of Blood and Marrow Transplantation. 2019; doi:10.1016/j.bbmt.2018.11.016.
  20. Chen YB, et al. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. Blood Advances. 2019; doi:10.1182/bloodadvances.2018027599.
  21. Ballen KK, et al. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: Comparison among alternative graft sources. Biology of Blood and Marrow Transplantation. 2014; doi:10.1016/j.bbmt.2014.07.021.
  22. Sweeney SK, et al. Tracking embryonic hematopoietic stem cells to the bone marrow: Nanoparticle options to evaluate transplantation efficiency. Stem Cell Research & Therapy. 2018; doi:10.1186/s13287-018-0944-8.
  23. Kumar A, et al. Antithymocyte globulin for graft-versus-host disease prophylaxis: An updated systematic review and meta-analysis. Bone Marrow Transplantation. 2019; doi:10.1038/s41409-018-0393-0.
  24. Graff TM, et al. Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Bone Marrow Transplant. 2015; doi: 10.1038/bmt.2015.46.
  25. Brown AY. Allscripts EPSi. Mayo Clinic. Sept. 16, 2019.
  26. Search for a FACT accredited organization. Foundation for the Accreditation of Cellular Therapy (FACT). Accessed Aug. 13, 2019.
  27. Transplant center search results. Be The Match. Aug. 13, 2019.
  28. Participating transplant centers. Center for International Blood and Marrow Transplant Research. Accessed Aug. 13, 2019.
  29. Locations. Children's Oncology Group. Accessed Aug. 13, 2019.
  30. Participating institutions. ECOG-ACRIN Cancer Research Group. Accessed Aug. 13, 2019.
  31. PBMTC members. Pediatric Blood and Marrow Transplant Consortium. Accessed Aug. 13, 2019.
  32. Participating clinical centers. Primary Immune Deficiency Treatment Consortium. Accessed Aug. 13, 2019.